Bullous/Blistering Skin Disorders

Questions discussed in this category

How have you applied the findings of this trial to your current approach to prescribing rituximab for pemphigus patients?

Do you have concerns that the 52 week follow up period may be insufficient to capture the full relapse pattern and risk, especially considering publis...

3 Answers available

How do you counsel patients with pemhigus on the main safety benefits of a low or ultra low dose rituximab regimen?

Do you feel these are clinically meaningful?

2 Answers available

Do you change your approach to prednisone taper based on rituximab dosing regimen when treating patients with pemphigus?

2 Answers available

Are there subgroups of patients with pemphigus in whom you prioritize lower-dose rituximab regimens?

What clinical factors guide this? Age, coborbidities, disease duration, disease severity?

2 Answers available

How do you tailor rituximab dosing for mucosal-predominant vs mucocutaneous pemphigus?

Does phenotype change your approach to dosing?

2 Answers available

What is your approach to tapering off rituximab in a patient with pemphigus who seems to be remission?

Do you prefer to decrease dose or space out doses, or both?

2 Answers available

What are your preferred treatment options for recalcitrant pemphigus vulgaris?

1 Answer available

How do you manage pemphigus patients who have persistent disease and circulating autoantibodies despite two full courses of rituximab?

2 Answers available

Should nivolumab be discontinued in a patient who develops bullous pemphigoid but is otherwise responding well to therapy, if BP is being managed with dupilumab?

1 Answer available

Does the presence of paraneoplastic pemphigus influence your treatment options in CLL?

1 Answer available

How do you approach postoperative radiation therapy in a patient with head and neck cancer who has high risk of recurrence in the setting of active epidermolysis bullosa?

2 Answers available

Would you utilize rituximab or dupilumab for treatment resistant bullous pemphigoid?

4 Answers available

What treatment combination approach would you recommend for mucous membrane pemphigoid?

3 Answers available

Are there patients with pemphigus whom you plan to give additional doses of rituximab even if they are in complete remission at six months from their initial dose?

1 Answer available

How would you approach treating patients with biopsy-proven Hailey-Hailey disease refractory to multiple oral therapies (i.e. tetracyclines, naltrexone, apremilast, glycopyrrolate, Cellcept), and requiring monthly steroid tapers for disease flares?

The disease is responsive to ablative lasers however laser treatments are not an option.

5 Answers available

Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?

The patient's lesion is a biopsy-proven adenocarcinoma that has grown over the past several months. They have bullous pemphigoid which is being treate...

2 Answers available

What is your approach to tapering treatments for patients with bullous pemphigoid?

2 Answers available

What is your stepwise approach to a patient with erosive gingivitis?

What treatment do you initiate before you have a clear diagnosis?

1 Answer available

What is your approach to management of radiation-induced bullous pemphigoid?

1 Answer available

How would you treat pemphigus foliaceous in an elderly patient intolerant to oral steroids?

2 Answers available

What initial workup do you perform when there is a concern for porphyria?

1 Answer available